Medlab Middle East spotlights AI in African diagnostics as the 24th edition of the event concludes
The event returns in February 2026 as WHX Labs Dubai
Dubai, United Arab Emirates: Amid rapid transformation in Africa's healthcare sector, Medlab Middle East hosted a dedicated session today on ' Doing Business in Africa - Transforming Diagnostic Business Models with AI and other Technologies to Access New Markets '. Led by the African Business Coalition for Health (ABCHealth), the event brought together industry leaders, policymakers and healthcare innovators to explore AI-driven solutions and the technological advancements shaping Africa's diagnostics landscape.
With growing healthcare demands and underserved markets, Africa presents significant opportunities for businesses leveraging AI, automation and data-driven solutions. The ABCHealth session highlighted the innovative approaches, key market-entry strategies, and technology-driven collaborations that enable businesses to tap into Africa's dynamic and evolving healthcare ecosystem, fostering sustainable growth and improved health outcomes.
During the welcome address, Dr Mories Atok i, CEO, African Business Coalition for Health (ABCHealth), Nigeria said: 'Whether you represent a government body, a private enterprise, or an academic institution, the contributions today matter. Together, we have the opportunity to overcome barriers and harness the power of artificial intelligence and other technologies to transform the diagnostics business models that will define the future of healthcare in the African continent. Today is about maximising the opportunities to exchange ideas, network, connect and inspire one another.'
The opening keynote session by Professor Hatem Mostafa ElGabaly, Former Minister of Health, Egypt, highlighted the importance of African countries and the opportunities to support and promote businesses from the country.
He said, 'The current state of health diagnostics in Africa is prohibited by the limited access to advanced diagnostic tools. In some regions, there is only one radiologist per 500,000 people. In addition, there is a high disease burden with an inadequate healthcare infrastructure. Africa accounts for 24% of the global disease burden but only 3% of the global health workforce. This underscores the importance of investment, which has the potential to improve health outcomes and economic growth, as well as utilising technology to leapfrog traditional healthcare models.'
In addition to the Africa-focused session, Medlab Middle East has hosted two high-level breakfast forums this week, which brought together global and regional laboratory leaders to discuss the key issues shaping the future of diagnostics and healthcare.
The Global Lab Leaders Breakfast Forum gathered Medlab portfolio global advisers, scientific chairs, international partners and stakeholders to tackle the global harmonisation of laboratory practices. Discussions at the new forum also explored the critical role of labs in managing global health crises, fostering international collaboration, and shaping the future of laboratory medicine.
Themed 'Strengthening cooperation amongst laboratories in the GCC', the GCC Lab Leaders Forum at Medlab Middle East brought together officials, experts and specialists from both public and private sector laboratories and national standardisation bodies across the region. The forum focused on strengthening laboratory networks region-wide, with topics addressed including career pathways for medical laboratory professionals and the formation of a GCC medical lab alliance.
Medlab Middle East concludes today having featured over 800 exhibitors from over 40 countries and welcoming an expected attendee count of 20,000 visitors. In addition to the ABCHealth Forum and Leaders' Breakfast Forums, new features this year have included the Women's Health Leadership Forum, Precision Medicine Leadership Forum and the CME-accredited Lab Automation conference track.
The event has brought together exhibitors and visitors from more than 180 countries, providing an unrivalled platform to showcase the latest innovations and discover a wide variety of cutting-edge medical laboratory products and services.
The key product categories showcased at Medlab Middle East are Disposable, Healthcare/General Services, Imaging, Infrastructure, IT, Laboratory, Medical Equipment and Pharma/Nutrition. Industry leaders featured at the event include Al Borg Diagnostics, Fujifilm Middle East FZE, Horiba ABX SAS, Sysmex Middle East, Randox Laboratories and Snibe.
After 24 years of success, Medlab Middle East is evolving into WHX Labs Dubai, uniting with the World Health Expo (WHX) to foster greater global collaboration, innovation and impact in the laboratory industry. WHX Labs Dubai will be joined by city-based events in Lagos, Cape Town, Nairobi, Kuala Lumpur and Bangkok to strengthen relationships and accelerate knowledge sharing. The inaugural WHX Labs Dubai will take place from 9 to 12 February,2026.
About Medlab Middle East
As the MENA region's most prominent medical laboratory exhibition and congress, Medlab Middle East plays a crucial role in advancing the value of laboratory medicine worldwide, shaping the future of diagnostics by providing an international platform for laboratory industry leaders, including manufacturers, dealers and distributors to share best practice, showcase innovations, collaborate and network.
Medlab Middle East stems from 15 years of growth alongside the MENA region's largest healthcare event, Arab Health. Now in its 24th year, this annual medical laboratory meeting brings together exhibitors and attendees from over 180 countries.
Medlab Middle East will take place from 3 – 6 February 2025 at the Dubai World Trade Centre, Dubai, UAE. A digital event will occur from 4 December – 20 February 2025.
Website: medlabme.com
Facebook: facebook.com/medlabseries
Twitter: @MedlabSeries #myMedlab
Instagram: @medlab.series
LinkedIn: Medlab Middle East
For more information, please get in touch with Shamal Communications:
Media Contact
CATHERINE ALLTOFT
ACCOUNT DIRECTOR
E-mail : catherine.alltoft@shamalcomms.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
11 minutes ago
- Zawya
Madagascar Shows Commitment to Improving Cancer Care, with Focus on Women's Health
An international review has found that Madagascar has laid strong foundations for cancer control, expanding cervical cancer services, maintaining a health workforce and ensuring collaboration between health and radiation safety authorities. The joint imPACT review by the IAEA, World Health Organization (WHO) and International Agency for Research on Cancer (IARC, highlighted the need to further develop oncology professionals and mobilize resources to increase access to cancer care across the country. Cancer claims more than 14 000 lives in Madagascar every year, with women more affected than men with 8 000 deaths. The country registers over 20,000 new cancer cases annually, according to 2022 IARC estimates. Incidence rates are expected to rise with increasing risk factors and an aging population. In June 2025, a team of 13 international experts nominated by the three organizations visited the main healthcare and specialized facilities in the country to conduct the imPACT review – which provides a baseline assessment of services to support Madagascar as the country develops its first comprehensive national cancer governance document. The experts held discussions with national and local health authorities, medical professionals and other stakeholders, and presented preliminary findings to the Minister of Health. 'The Malagasy government is committed to improving cancer care in the country,' Minister of Health Randriamanantany Zely Arivelo said. 'This imPACT assessment is very timely, as we will use its findings to finalize our country's first national cancer control plan.' Focus on Women's Cancers The most common cancer among women in Madagascar is cervical cancer, with a mortality rate of 30 per cent, followed by breast and colorectal cancers. In men, prostate, liver cancer and non-Hodgkin lymphoma are the most common cancers, driven by infectious diseases. The team assessed all elements that can impact cancer care in the country. These include factors such as governance, resources and regulatory frameworks for radiation safety, and components such as surveillance, referral networks, early diagnostic capacities, oncology workforce development opportunities, and readiness for advanced and expanded radiotherapy services. 'The strength of the imPACT review lies in its analysis of the entire cancer continuum,' said Laurent Musango, WHO Representative in Madagascar. 'The assessment reveals a solid foundation for integrating cancer control at the community level, and the potential for an overall strengthening of health systems in terms of prevention and early diagnosis.' The review found that Madagascar has been steadfast in boosting cancer services since a previous assessment in 2015. The country has expanded cervical cancer prevention, with pre-cancerous lesion screening already available and HPV vaccination set to start in October and has undertaken important efforts to modernize and distribute imaging services. The national health system also has an established and overall qualified health workforce, with six faculties of medicine available to train specialized health professionals – particularly in surgery, a critical aspect in cancer treatment. Boosting Capacity for Cancer Care The team recommended that Madagascar continue building capacity to increase and retain human resources in oncology professionals. It also urged further strengthening of radiation safety in medicine and long-term maintenance of existing equipment in nuclear medicine and radiotherapy centres. 'Radiation safety for the protection of patients, public and staff is foundational to providing comprehensive cancer diagnosis and treatment,' said Vasiliki Kamenopoulou, a radiation safety specialist at the IAEA who participated in the imPACT review. 'The Malagasy government is encouraged to reinforce the legal and regulatory framework for safety and bring it in line with the IAEA safety standards.' The review noted that Madagascar should also reinforce prevention and early detection actions for other priority cancers, including working with communities for greater breast cancer awareness and boosting pathology services with additional laboratory staff, equipment and supplies. Partnerships to Expand Services Looking forward, the imPACT review recommended strategies to support Madagascar mobilize resources for cancer control, such as the development of bankable documents to facilitate loans and public-private sector partnerships. The IAEA's Programme of Action for Cancer Therapy and Rays of Hope initiative support countries in bridging gaps in cancer care through partnerships with donors, the private sector and financial institutions. Through its technical cooperation and human health programmes, the IAEA also supports countries in strengthening the quality of nuclear and radiation medicine by providing capacity building, provision of equipment, technical advice and advisory services. Distributed by APO Group on behalf of International Atomic Energy Agency (IAEA).
Zawya
2 hours ago
- Zawya
Tokyo International Conference on African Development (TICAD9): African Development Bank to focus on partnerships and investment at 9th Tokyo International Conference on African Development
The African Development Bank ( will participate in the 9th Tokyo International Conference on African Development (TICAD9) ( taking place in Yokohama, Japan from 20-22 August. This year's conference takes place at a critical time as Africa seeks to close investment gaps and build resilience to global economic and climate shocks. The African Development Bank stands as a key driver of this transformation for the continent, leveraging its leadership to mobilise international support, particularly from Japan. Co-hosted by United Nations, United Nations Development Programme (UNDP), The World Bank and African Union Commission (AUC), TICAD has been running for more than three decades since the first conference, TICAD I, in 1993. The forum has proved itself a solid catalyst to Africa's development agenda, mainly through grant aid and technical assistance. Among the delegates from the African Development Bank attending the conference are Kevin Kariuki, Vice President for Power, Energy, Climate and Green Growth; Solomon Quaynor, Vice President for Private Sector, Infrastructure, Industrialisation; Nnenna Nwabufo, Vice President for Regional Development, Integration and Business Delivery; Kevin Urama, Chief Economist and Vice President for Economic Governance&Knowledge Management, and several directors. Over the years, the African Development Bank's collaboration with Japan through TICAD, has evolved into a dynamic platform for development finance, knowledge exchange, and private sector engagement. Through programmes like the Enhanced Private Sector Assistance (EPSA) initiative, Japan's support to the Bank has resulted in billions in co-financing for African businesses and infrastructure as well as important support to capital replenishment. In addition, strategic partnerships with Japanese agencies such as Japan International Cooperation Agency (JICA), Japan Bank for International Cooperation (JBIC), Nippon Export and Investment Insurance (NEXI), continue to advance the Bank's High 5 development goals. These partnerships have supported transformative projects in energy, transport, health, and climate resilience across the continent. Enhanced Private Sector Assistance for Africa (EPSA) The Enhanced Private Sector Assistance for Africa or EPSA ( Initiative, is a framework for resource mobilization and development partnership to support the implementation of the Bank's Strategy for Private Sector Development. Drawing on successful development experience in Asia and around the globe, EPSA, which was conceived in partnership with the Government of Japan in 2005, consists of four main pillars: (1) Accelerated Co-financing Facility for Africa (ACFA), (2) Non-Sovereign Loans (NSL), (3) Fund for African Private Sector Assistance (FAPA), and (4) Private sector investment finance. An extension of the agreement - EPSA6 - is expected to be signed during TICAD9. Recognizing the private sector's importance in African development, the African Development Bank will host side events to encourage Japanese investment in key areas such as green hydrogen, Mission 300 ( transportation, health, agriculture, and education. The Africa Investment Forum ( a partnership of the African Development Bank and eight other institutions will also be promoted as an innovative investment marketplace for attracting capital for projects on the continent. During the Forum's Market Days held in December 2024 in Morocco, a special event raised awareness about Africa as an investment destination for Japanese investors. The Japan Special Room titled: 'Agricultural Innovation&Green Growth: Transforming Africa's Investment Landscape' was organized with approximately 100 participants, including representatives from Japanese companies, startups, and other public institutions. Accessing Resilient Energy for Africa On Tuesday, a day before the official opening of TICAD9, an event organized by JICA and other partners highlighted one of the continent's major challenges - the energy gap in Africa. Over 200 representatives from government, ministers and development partners attended the ' Harnessing Innovation, Co-creation, and Knowledge for Accessible and Resilient Energy for Africa," event, which was held in person and online. Without energy, the bedrock of infrastructure for crucial development cannot be realized. Yet persistent underinvestment in energy infrastructure is one of the continent's major hurdles, African Development Bank Director of Energy Financial Solutions, Policy and Regulation Department Wale Shonibare, who moderated the session said. Setting the stage for the conversation, he said Africa's 600 million people without access to reliable energy represent 83% of people with energy access lack globally affecting 2 out of 3 Africans. A further 900 million have no access to clean cooking, while Nigeria DRC, Ethiopia, Uganda and Tanzania together have half the population of no access, Shonibare said. Stressing the significance of TICAD as a platform to provide innovation and solutions through partnerships and investment, he noted: 'We see enormous potential in Africa's regional power pools…Today's session is both timely and catalytic.' The African Development Bank will organize several sessions covering a range of key development topics during the TICAD. Among these, two flagship events will be co-hosted in partnership with the Ministry of Finance. Further details on these events can be found below. High-Level Policy Dialogue: Harnessing the Potential of Africa (Link) ( Date: Thursday, 21 August Time: 10:00 AM - 11:30 AM (Tokyo time) Venue: S-01, Hall D, PACIFICO Yokohama&Zoom High-Level Business Session: Emerging Partnership between Japan and Africa (Link) ( Date: Thursday, 21 August Time: 12:40 PM - 2:10 PM (Tokyo time) Venue: S-01, Hall D, PACIFICO Yokohama&Zoom ( Learn more about the TICAD9 conference here ( Distributed by APO Group on behalf of African Development Bank Group (AfDB). Contact: Amba Mpoke-Bigg Communication and External Relations Department email: media@ Yuna Choi email: About the African Development Bank Group: The African Development Bank Group is Africa's premier development finance institution. It comprises three distinct entities: the African Development Bank (AfDB), the African Development Fund (ADF) and the Nigeria Trust Fund (NTF). On the ground in 41 African countries with an external office in Japan, the Bank contributes to the economic development and the social progress of its 54 regional member states. For more information:
Zawya
4 hours ago
- Zawya
From genome to action: Building Sierra Leone's next generation of genomic leaders for public health resilience beyond mpox
Sierra Leone has taken an important step in strengthening its public health system by hosting a two-week national workshop on DNA sequencing and bioinformatics from August 4 to August 15, 2025 in Freetown. The training, held under the theme 'From Genome to Action: Enhancing Mpox Surveillance through Sequencing and Bioinformatics in Sierra Leone,' was supported by the World Health Organization (WHO). It focused on building the country's capacity to track and understand diseases through genomic science, with mpox as a key focus, but also extending to other infectious diseases. The training served as a mentorship program for 16 young scientists, 15 of whom had already received foundational genomics training with WHO support. This advanced phase transitioned them to mid-level genomic experts capable of sophisticated data analysis and interpretation to inform real-time public health interventions. The sessions were practical and hands-on, covering: DNA sequencing: learning how to read and understand genetic material using Illumina platforms. Bioinformatics analysis: interpreting genetic information to see how diseases spread and change. Data stewardship: submitting results to international databases to support global knowledge. Outbreak analytic: turning genetic information into actions that help control outbreaks. The comprehensive program went beyond mpox, also covering diseases like Ebola, COVID-19, Lassa fever, HIV, and antimicrobial resistance. It also introduced broader tools that allow scientists to study different types of pathogens at once. Already, the Central Public Health Reference Laboratory (CPHRL) is applying these skills in HIV-2 research. 'This is mentorship in motion. We're growing future genomic leaders from within,' said Doris Harding, Laboratory Lead at the National Public Health Agency (NPHA). As of August 18, 2025, Sierra Leone had sequenced 10.1% (522 out of 5,154) of its confirmed mpox cases, meeting both national and continental targets of 8–10%. This progress shows how far the country has come, but also highlights the need to maintain momentum. By training participants from start to finish - sample collection to reporting, the workshop not only boosted mpox surveillance but also set the stage for sustainable genomic monitoring systems. 'This is sustainability in action – building resilient systems by empowering the laboratory pillar,' emphasized Dr. Ameh George, WHO Representative to Sierra Leone. Participants shared how the training had impacted them: 'We are deeply grateful for this investment in capacity building. The opportunity has not only enriched our professional knowledge but has also given us confidence to contribute meaningfully to research and health systems,' said Abu Bakarr Sawaneh from Connaught lab. Vidalyn Folorunso, a Medical Laboratory Scientific Officer from CPHRL added, 'Let us keep practicing, applying the knowledge gained, and making good use of it in our institutions.' Allan Campbell, CPHRL Lead&DNA Sequencing Training Lead, highlighted the lasting benefits: 'This mentorship-driven model not only meets today's needs but also builds a pipeline of future genomic experts. By empowering local scientists with the ability to lead using data and speed, Sierra Leone is strengthening its role in regional and global health security—whether in Mpox, HIV, cancer, antimicrobial resistance, or Ebola.' Walter Oguta, WHO AFRO EPI Analytics Specialist&Bioinformatics Training Lead, underscored the bigger picture: 'The workshop was a pivotal step in embedding genomic science into Sierra Leone's health system. By training a new generation of scientists, the country is now better positioned to respond to outbreaks with data-driven precision.' The August 2025 workshop stands as a milestone in Sierra Leone's public health journey. By combining mentorship, advanced training, and a focus on sustainability, it has built a new generation of scientists ready to lead the country's response to present and future health threats. This effort marks the beginning of a stronger, data-driven foundation for health security in Sierra Leone. Distributed by APO Group on behalf of World Health Organization - Sierra Leone.
